← Back to Search

Behavioural Intervention

Neurofeedback for Adolescent Depression

N/A

Waitlist Available

Led By Mary Woody, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants will include 90 female adolescents ages 13 years 0 months through 15 years 11 months at study entry.

Be younger than 18 years old

Must not have

Being pre-pubertal

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and following laboratory stressor (~30 minutes)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing if a new method can be used to help predict and treat depression in adolescents, specifically by looking at how they react to positive and negative stimuli.

Who is the study for?

This trial is for female adolescents aged 13 to nearly 16 who may be at risk for depression. They must have normal intelligence, no history of neurological issues or serious medical conditions, and cannot have taken antidepressants or have a history of certain mental health disorders.

What is being tested?

The study tests if a new method using EEG can predict depression in teens and if neurofeedback can change how they pay attention to emotions, possibly preventing mood problems later on.

What are the potential side effects?

Neurofeedback is generally considered safe but might cause temporary discomfort like headaches or fatigue. Since it's non-invasive, there are minimal risks associated with the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a girl aged 13 to 15 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not started puberty.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and following laboratory stressor (~30 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and following laboratory stressor (~30 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and following laboratory stressor (~30 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from baseline in affect-biased attention subsequently following neurofeedback (~1 hour)

Secondary study objectives

Change from baseline in anxiety after laboratory stressor, which follows neurofeedback

Change from baseline in sadness after laboratory stressor, which follows neurofeedback

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: NeurofeedbackExperimental Treatment1 Intervention

Participants will receive feedback about their attention to negative distractors during each trial using activity from their brain waves, which will help them reduce their attention to distractors.

0 / 2Eligibility criteria met